Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Non-intrusive solution for Obstructive Sleep Apnea Syndrome

Project description

Novel test for detecting obstructive sleep apnoea

Obstructive sleep apnoea (OSA) is a condition associated with the collapse of the upper airway during sleep. It is caused by the excessive relaxation of the muscles that support the throat and tongue. Diagnosis involves spending the night in a sleep laboratory and undergoing a polysomnography test. Scientists of the EU-funded Sleepwise project have developed a less intrusive approach for detecting OSA as well as other sleep-related disorders and epilepsy. The test relies on image processing during sleep/awake periods, does not require extensive training, and importantly, it is suitable for use in children.

Objective

The Obstructive Sleep Apnea (OSA) is a chronic disease that afflicts approximately 100 million people, however, nearly 80%
of people with this condition remain undiagnosed. Sleep Apnea has serious medical consequences but it is also
economically costly. In the USA alone the estimated economic cost of undiagnosed OSA is $149.6 billion.
The diagnosis of OSA is typically made after a polysomnography (PSG), an expensive test that requires an overnight stay in
a sleep laboratory wired to up to 15 different devices. Today the use of Home Sleep Tests are increasing due to are less
intrusive and cheaper, however, they are subject to patient error in attaching the sensors, require previous training, are
cumbersome and are not appropriate for children.
Tarsio Medics is a technological company that has been working during more than 10 years together with the Pneumology
unit of the Hospital Trias i Pujol to develop SleepWise, an innovative system for the exploration and diagnosis of OSA based
on image processing.
Our patented SleepWise system is non-intrusive, low cost, does not require training. It provides automatic analysis for sleep
professionals, is more reliable because it can infer sleep/awake periods and is more versatile as it can also detect other
nocturnal movements such as restless legs, parasomnias and epilepsy.
We plan to monetize SleepWise offering a complete end-to-end service to doctors, hospitals and health insurance
companies. The market potential is large: the global sleep apnea diagnostic system market is €341.7 €205.06 of them
related with Home Sleep Tests.
Currently we have a beta version of the SleepWise. Now we are applying to the SME Instrument Phase 1 to carry out a
Feasibility Study to assess operational, technological and economic viability as well as to elaborate a Business Plan to
define the business growth, sustainability, exploitation strategies and tactics to follow paving the way to a global market.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

SME-1 - SME instrument phase 1

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) H2020-EIC-SMEInst-2018-2020

See all projects funded under this call

Coordinator

TARSIO MEDICS SL
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 50 000,00
Address
CALLE DE MAR 15 2-1
08380 MALGRAT DE MAR
Spain

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
Este Cataluña Barcelona
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 71 429,00
My booklet 0 0